(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoyl)-L-glutamic-13C5-15N acid
Pralatrexate-13C5-15N is a fully characterized chemical compound used as a reference standard of API Pralatrexate. The standard offered is compliant with regulatory guidelines. Pralatrexate-13C5-15N is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
